Vicus Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Vicus Capital's AMGN Position: Q1 2026 in Review
Vicus Capital sold out of Amgen (AMGN) in Q1 2026, closing a stake of 678 shares — an estimated $222K sold.
Vicus Capital first reported a position in AMGN in Q3 2016 and held it in 18 quarters. The position peaked at $400K in Q3 2017. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Vicus Capital reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
- Vicus Capital sold 678 Amgen shares in Q1 2026, an estimated $222K.
- Vicus Capital first reported a position in Amgen in Q3 2016 and held it in 18 quarters.
- Vicus Capital's Amgen position peaked at $400K in Q3 2017.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Vicus Capital's 13F filing for Q1 2026, filed 22 Apr 2026.